We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Surgical Scrub Solution Protects Patients Too

By HospiMedica International staff writers
Posted on 25 Sep 2009
Giving critically ill hospital patients a daily bath with chlorhexidine can dramatically cut down the number of patients who develop potentially deadly bloodstream infections, according to a new study.

Researchers from Johns Hopkins [University] Hospital (Baltimore, MD, USA) and five other institutions tracked daily neck-to-toe sponge baths given to 2,650 intensive care unit (ICU) patients at six different U.S. More...
hospitals between December 2004 and January 2006. The study patients were bathed with a mild, 4% solution of chlorhexidine glutonate, while an equal number of control patients were bathed with plain soap and water. Each patient was tested for infectious bacteria within 48 hours of admission and then weekly thereafter with either nasal or buttock swabs, and for the remainder of their hospital stay.

Weekly swab testing found 32% fewer patients colonized with methicillin-resistant Staphylococcus aureus (MRSA) and 50% fewer cases of vancomycin-resistant Enterococci (VRE), compared to the control subjects. Among some 500 patients whose stay in hospital was longer (at least 10 days), 11 who were washed with chlorhexidine had MRSA, and 5 developed bloodstream infections. By contrast, MRSA was detected in 27 of the control group, 8 developing bloodstream infections. Similarly, with VRE, 9 patients in the chlorhexidine group had bloodstream infections, while 33 were infected in the plain-soap group. No skin rashes or adverse events were detected in the study group during the test period. The study was published in the June 2009 issue of the journal Critical Care Medicine.

"Our results show that using chlorhexidine as a daily washing agent is a simple, effective and relatively cheap way to protect the health of our most vulnerable patients," said study co-investigator Trish Perl, M.D., director of hospital epidemiology and infection control at Johns Hopkins. "Altering the daily bathing routine is a simple and effective means of doing so because it involves no additional workload for nurses."

Chlorhexidine is a chemical antiseptic that is bactericidal to both Gram-positive and Gram-negative microbes; it is also bacteriostatic. The mechanism of action is by membrane disruption, and not ATPase inactivation as previously thought. It also shows activity with enveloped viruses, though this has not been extensively investigated. Chlorhexidine gluconate is often used as an active ingredient in mouthwashes designed to reduce dental plaque and oral bacteria, and also as a skin cleanser, mainly used as a surgical scrub, but is also available as a wound wash.

Related Links:

Johns Hopkins Hospital




Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.